test altFunding OpportunitiesAward ManagementComliance Review and OversightEducation and TrainingTechnology Transfer
Office of Research and Technology Management
Promoting Research, Advancing Scholarship, Fostering Innovation
Identify Funding Oportunities Proposal Development Award Management
Compliance Review and Oversight Education and Training Technology Transfer


Welcome from the Vice President for Research

CWRU researchers are among the most distinguished in the world. We have 16 Nobel Laureates among current and former faculty and alumni, 4 members of the National Academies of Sciences, 7 members of the National Academy of Engineering, and 8 members of the Institute of Medicine. We also partner with artistic and cultural institutions on a broad range of projects that make important scholarly contributions in the humanities and social sciences.

Extraordinary research requires an outstanding infrastructure. Our Office of Research & Technology Management provides support to seek out grant funding, to facilitate industrial sponsorship, and to transfer university technologies to the marketplace. This is a place for people driven to make a difference, and our office exists to help them succeed.

Contact us. We want you to see what our campus can offer.

Dr. Suzanne Rivera


Research Matters

Research Matters

Use the following link in order to view previous editions of Research Matters and Research News and Updates Research Matters Archive .




Latest News

Research Newsletter
July 14, 2015  

Take Advantage of All Pivot Has to Offer

For years, Community of Science (COS) has been recognized around the world for its funding from a wide variety of sources as well as its access to the world’s research community.

CWRU has subscribed to COS's new product, Pivot, which provides you the edge by bringing together the right research opportunities, funding, and people—quickly and easily. It provides global and local connections that strengthen research by exploring new avenues for funding and collaboration—for faculty, staff researchers, and graduate students.

Pivot can:

  • provide access to the most comprehensive global source of funding opportunities;
  • identify research expertise from within or outside of CWRU;
  • foster collaboration by cultivating essential partnerships and alliances; and
  • build strong network connections for future opportunities.
Learn more about how to use all the features Pivot has to offer.

Sign up for a Pivot Webinar: https://refworks.webex.com/refworks/onstage/g.php?p=4&t=m.

 
Interested in applying for an NCAI grant?

The NHLBI-funded NIH Center for Accelerated Innovations (NCAI) at Cleveland Clinic has recently established monthly one-on-one meeting opportunities for investigators interested in the NCAI program for developing their cardiovascular, lung, blood, or sleep disorder technologies.

These on-site meetings are designed to promote the program and encourage individual discussion opportunities with NCAI program managers. The NCAI is committed to providing ongoing engagement with investigators from across CWRU schools and departments to build a pipeline of projects for the program funding cycles. These information sessions will focus on investigator readiness and the funding requirements of the NCAI.

If you are interested in attending one of these sessions, please contact Denise Miller at 216-368-1158 or dmm192@case.edu to set up a meeting with one of the NCAI program managers. All meetings will be held on the CWRU campus starting Thursday, July 9th, and on the third Thursday of each month thereafter. Meetings will be scheduled in the afternoons.

If you have questions or would like more information, please contact Anne DeChant in the SOM Office of Translation and Innovation (akd6@case.edu,216-368-8867).

 
PCORI: Engagement Award: Knowledge, Training and Development, and Dissemination Awards

The Patient-Centered Outcomes Research Institute (PCORI) will award up to $15.5 million in FY 2015 as part of the Eugene Washington PCORI Engagement Awards program. These awards support projects that encourage active integration of patients, caregivers, clinicians, and other healthcare stakeholders as integral members of the patient-centered outcomes research/clinical effectiveness research (PCOR/CER) enterprise.

A letter of intent is due October 1, 2015

For more information visit the PCORI webpage.

 

Bristol-Myers Squibb

The Bristol-Myers Squibb Fellows Research Program is a key component of an ongoing and concerted effort by Bristol-Myers Squibb Virology and Immunoscience to advance research and understanding in the areas of HIV/AIDS, chronic hepatitis and rheumatoid arthritis. The program provides support for fellows to gain experience in epidemiological and clinical research as it relates to the care of individuals living with HIV/AIDS, chronic hepatitis C virus (HCV), and rheumatoid arthritis (RA).

Goals of the Program:

  • Support studies that will further strengthen the science and knowledge of HIV/AIDS, HCV and RA clinical research
  • Support the development of future clinical researchers


Application Deadline: July 31, 2015

For more information, please refer to the attached flyer.

 
Limited Submission Reminder: W.M. Keck Foundation Research Program

Key Deadlines: June 15, 2015 (CWRU internal LOI), November 1, 2015 (Sponsor Deadline).

The W.M. Keck Foundation Research Program seeks to benefit humanity by funding fundamental, high-risk research in two specific areas: 1) medical research and 2) science and engineering. Both Senior and Early Career investigators are encouraged to apply. CWRU may submit two proposals per funding cycle: one (1) in Medical Research and one (1) in Science and Engineering Research.

Applicants are encouraged to consult with their Associate Deans for Research prior to internal submission to assure they meet eligibility criteria and their projects meet stated program objectives.

Grants of up to $1 million over 3 years are awarded for projects in science and engineering research and medical research that:

  • Focus on basic, early stage, emerging areas of research, not on clinical or translational research, treatment trials or research for the sole purpose of drug development.
  • Have the potential to develop breakthrough technologies, instrumentation or methodologies.
  • Have few, if any, peer groups pursuing comparable or related work.
  • Have high level of risk due to unconventional approaches, or by challenging the prevailing paradigm.
  • Have the potential for transformative impact, such as the founding of a new field of research, the enabling of observations not previously possible, or the altered perception of a previously intractable problem.
  • Fall outside the mission of public funding agencies. Provide specifics. If you've been declined federal funding, provide the documentation stating why, if available.
  • Demonstrate that the W. M. Keck Foundation's support is essential to the project's success.


For more information on this limited submission opportunity, visit the Office of Research Administration website.

 

If you have news or information that you wish to have included in this update, please send it via e-mail to Tracy Wilson-Holden at tracy.wilson-holden@case.edu no later than 5 pm on the Monday of the week that the update is to be distributed. If you know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe to Case Research News, email your request to Tora Williams at tora.williams@case.edu.

Please note: At the time of this transmission, all links functioned. However, Case Research News cannot guarantee that the information will not move or be deleted.